For patient-related information about the ICT-107 cancer vaccine phase II program please:

  1. Access the ICT-107 FAQ (Frequently Asked Questions) click here.
  2. Send an email message to clintrials@imuc.com, including your contact information and your specific questions.
  3. Call 818 264 2315 and leave a brief message, including your contact information and questions.

Someone knowledgeable about the ICT-107 clinical program will respond to your inquiry shortly.

PRESS RELEASES

Sunday, June 01, 2014
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed read more ...
Thursday, May 08, 2014
ImmunoCellular Therapeutics Announces First Quarter 2014 Financial Results read more ...
Thursday, May 01, 2014
ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2014 on May 8, 2014 read more ...
Monday, April 21, 2014
ImmunoCellular Therapeutics Announces ICT-107 Phase II Data Abstract Accepted for Oral Presentation read more ...
Thursday, March 13, 2014
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results read more ...
Tuesday, March 11, 2014
ImmunoCellular Therapeutics Announces Change to Meeting Date for Annual Meeting of Stockholders read more ...

EVENTS

Thursday, May 08, 2014
ImmunoCellular is holding a conference call and webcast today at 5:00 pm ET
Thursday, May 01, 2014
ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2014 on May 8, 2014
Thursday, March 13, 2014
Immunocellular Therapeutics 4QYE 2013 Financial Results Conference Call and Webcast
 
Copyright 2014 by Immunocellular Therapeutics, Ltd.
All Rights Reserved